Abbott News

Pharmaceutical News from Abbott Laboratories

Abbott's XIENCE PRIME™ and XIENCE V® Receive Indications in Europe for Treatment of Patients with Diabetes

Abbott's XIENCE PRIME™ and XIENCE V® Receive Indications in Europe for Treatment of Patients with Diabetes

Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois

Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois

ZonePerfect Indulgence™ Nutrition Squares Give Chocolate Lovers a Sensible Sweet-Tooth Option

ZonePerfect Indulgence™ Nutrition Squares Give Chocolate Lovers a Sensible Sweet-Tooth Option

Abbott Reports 16.5 Percent Earnings Growth in Third Quarter; Raises Earnings Guidance for 2009

Abbott Reports 16.5 Percent Earnings Growth in Third Quarter; Raises Earnings Guidance for 2009

Novel Abbott Test That Aids in the Early Diagnosis of Acute Kidney Injury (AKI) Receives CE Mark

Novel Abbott Test That Aids in the Early Diagnosis of Acute Kidney Injury (AKI) Receives CE Mark

Syndicate content